Dr. Suzanne Dawn Turner
Researcher, Institute of Medical Genetics and Genomics
e‑mail: |
---|
Total number of publications: 34
2022
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Leukemia, year: 2022, volume: 36, edition: 3, DOI
-
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis
Molecular Cancer, year: 2022, volume: 21, edition: 1, DOI
-
PDGFR beta promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
Molecular Cancer, year: 2022, volume: 21, edition: 1, DOI
-
Primary Lymphomas of the Breast: A Review
JPRAS OPEN, year: 2022, volume: 32, edition: JUN, DOI
-
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK(+) anaplastic large cell lymphoma
Blood, year: 2022, volume: 139, edition: 5, DOI
2021
-
Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors
DISCOVER ONCOLOGY, year: 2021, volume: 12, edition: 1, DOI
-
Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy
BRITISH JOURNAL OF HAEMATOLOGY, year: 2021, volume: 192, edition: 2, DOI
-
Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients
British journal of haematology, year: 2021, volume: 193, edition: 6, DOI
-
Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL
Cancers, year: 2021, volume: 13, edition: 23, DOI
-
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis
Molecular Cell, year: 2021, volume: 81, edition: 19, DOI